191 related articles for article (PubMed ID: 35241935)
41. Systemic immune-inflammation index and ultrasonographic classification of breast imaging-reporting and data system predict outcomes of triple-negative breast cancer.
Wang P; Yue W; Li W; Luo Y; Li Z; Shao Y; He Z
Cancer Manag Res; 2019; 11():813-819. PubMed ID: 30697073
[TBL] [Abstract][Full Text] [Related]
42. Preoperative systemic immune-inflammation index predicts prognosis and guides clinical treatment in patients with non-small cell lung cancer.
Yan X; Li G
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32175568
[TBL] [Abstract][Full Text] [Related]
43. Prognostic role of the systemic immune-inflammation index and pan-immune inflammation value for outcomes of breast cancer: a systematic review and meta-analysis.
Cheng HW; Wang T; Yu GC; Xie LY; Shi B
Eur Rev Med Pharmacol Sci; 2024 Jan; 28(1):180-190. PubMed ID: 38235869
[TBL] [Abstract][Full Text] [Related]
44. Significance of a preoperative systemic immune-inflammation index as a predictor of postoperative survival outcomes in gastric cancer.
Inoue H; Kosuga T; Kubota T; Konishi H; Shiozaki A; Okamoto K; Fujiwara H; Otsuji E
World J Surg Oncol; 2021 Jun; 19(1):173. PubMed ID: 34118953
[TBL] [Abstract][Full Text] [Related]
45. Preoperative Systemic Immune-Inflammation Index (SII) as a Superior Predictor of Long-Term Survival Outcome in Patients With Stage I-II Gastric Cancer After Radical Surgery.
He K; Si L; Pan X; Sun L; Wang Y; Lu J; Wang X
Front Oncol; 2022; 12():829689. PubMed ID: 35296020
[TBL] [Abstract][Full Text] [Related]
46. Preoperative increased systemic immune-inflammation index predicts poor prognosis in patients with operable non-small cell lung cancer.
Gao Y; Zhang H; Li Y; Wang D; Ma Y; Chen Q
Clin Chim Acta; 2018 Sep; 484():272-277. PubMed ID: 29860033
[TBL] [Abstract][Full Text] [Related]
47. Nutritional Risk Index Predicts Survival in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy.
Chen L; Qi Y; Kong X; Su Z; Wang Z; Wang X; Du Y; Fang Y; Li X; Wang J
Front Nutr; 2021; 8():786742. PubMed ID: 35096932
[TBL] [Abstract][Full Text] [Related]
48. Prognostic value of prognostic nutritional index and systemic immune-inflammation index in patients with osteosarcoma.
Huang X; Hu H; Zhang W; Shao Z
J Cell Physiol; 2019 Aug; 234(10):18408-18414. PubMed ID: 30891768
[TBL] [Abstract][Full Text] [Related]
49. Increased systemic immune-inflammation index independently predicts poor survival for hormone receptor-negative, HER2-positive breast cancer patients.
Sun Y; Li W; Li AJ; Su H; Yue J; Yu J
Cancer Manag Res; 2019; 11():3153-3162. PubMed ID: 31114357
[No Abstract] [Full Text] [Related]
50. The ratio of hemoglobin to red cell distribution width predicts survival in patients with gastric cancer treated by neoadjuvant FLOT: a retrospective study.
Yılmaz A; Mirili C; Tekin SB; Bilici M
Ir J Med Sci; 2020 Feb; 189(1):91-102. PubMed ID: 31832860
[TBL] [Abstract][Full Text] [Related]
51. High systemic immune-inflammation index is a predictor of poor prognosis in patients with nonsmall cell lung cancer and bone metastasis.
Xu S; Cao S; Yu Y
J Cancer Res Ther; 2021 Dec; 17(7):1636-1642. PubMed ID: 35381733
[TBL] [Abstract][Full Text] [Related]
52. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
[TBL] [Abstract][Full Text] [Related]
53. Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected non-small cell lung cancer.
Guo W; Cai S; Zhang F; Shao F; Zhang G; Zhou Y; Zhao L; Tan F; Gao S; He J
Thorac Cancer; 2019 Apr; 10(4):761-768. PubMed ID: 30734516
[TBL] [Abstract][Full Text] [Related]
54. Systemic immune-inflammation index as a prognostic marker in HER2-positive breast cancer patients undergoing trastuzumab therapy.
Pang J; Ding N; Yin N; Xiao Z
Sci Rep; 2024 Mar; 14(1):6578. PubMed ID: 38503890
[TBL] [Abstract][Full Text] [Related]
55. Systemic Immune Inflammation Index and T-Staging Predict Prognosis in Patients with Muscle-Invasive Bladder Cancer.
Zhang X; Liu Q
Arch Esp Urol; 2023 Sep; 76(7):511-518. PubMed ID: 37867336
[TBL] [Abstract][Full Text] [Related]
56. Systemic Immune-Inflammation Index (SII) is Useful to Predict Survival Outcomes in Patients After Liver Transplantation for Hepatocellular Carcinoma within Hangzhou Criteria.
Fu H; Zheng J; Cai J; Zeng K; Yao J; Chen L; Li H; Zhang J; Zhang Y; Zhao H; Yang Y
Cell Physiol Biochem; 2018; 47(1):293-301. PubMed ID: 29768257
[TBL] [Abstract][Full Text] [Related]
57. Preoperative prognostic nutritional index and systemic immune-inflammation index predict survival outcomes in osteosarcoma: A comparison between young and elderly patients.
Ma C; Yu R; Li J; Guo J; Xu J; Wang X; Liu P
J Surg Oncol; 2022 Mar; 125(4):754-765. PubMed ID: 34811745
[TBL] [Abstract][Full Text] [Related]
58. The predictive value of a preoperative systemic immune-inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma.
Zhang H; Shang X; Ren P; Gong L; Ahmed A; Ma Z; Ma R; Wu X; Xiao X; Jiang H; Tang P; Yu Z
J Cell Physiol; 2019 Feb; 234(2):1794-1802. PubMed ID: 30070689
[TBL] [Abstract][Full Text] [Related]
59. Systemic immune-inflammation index predicts prognosis of bladder cancer patients after radical cystectomy.
Zhang W; Wang R; Ma W; Wu Y; Maskey N; Guo Y; Liu J; Mao S; Zhang J; Yao X; Liu Y
Ann Transl Med; 2019 Sep; 7(18):431. PubMed ID: 31700867
[TBL] [Abstract][Full Text] [Related]
60. Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer.
Tong YS; Tan J; Zhou XL; Song YQ; Song YJ
J Transl Med; 2017 Oct; 15(1):221. PubMed ID: 29089030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
